DRUG
Price
$35.45
Change
+$3.47 (+10.85%)
Updated
Jul 25 closing price
Capitalization
250.45M
HURA
Price
$2.85
Change
+$0.01 (+0.35%)
Updated
Jul 25 closing price
Capitalization
132.66M
Interact to see
Advertisement

DRUG vs HURA

Header iconDRUG vs HURA Comparison
Open Charts DRUG vs HURABanner chart's image
Bright Minds Biosciences
Price$35.45
Change+$3.47 (+10.85%)
Volume$96.52K
Capitalization250.45M
TuHURA Biosciences
Price$2.85
Change+$0.01 (+0.35%)
Volume$149.1K
Capitalization132.66M
DRUG vs HURA Comparison Chart in %
Loading...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRUG vs. HURA commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRUG is a StrongBuy and HURA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (DRUG: $35.46 vs. HURA: $2.85)
Brand notoriety: DRUG and HURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRUG: 226% vs. HURA: 50%
Market capitalization -- DRUG: $250.45M vs. HURA: $132.66M
DRUG [@Biotechnology] is valued at $250.45M. HURA’s [@Biotechnology] market capitalization is $132.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRUG’s FA Score shows that 0 FA rating(s) are green whileHURA’s FA Score has 0 green FA rating(s).

  • DRUG’s FA Score: 0 green, 5 red.
  • HURA’s FA Score: 0 green, 5 red.
According to our system of comparison, DRUG is a better buy in the long-term than HURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRUG’s TA Score shows that 4 TA indicator(s) are bullish while HURA’s TA Score has 4 bullish TA indicator(s).

  • DRUG’s TA Score: 4 bullish, 5 bearish.
  • HURA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DRUG is a better buy in the short-term than HURA.

Price Growth

DRUG (@Biotechnology) experienced а +35.53% price change this week, while HURA (@Biotechnology) price change was +8.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

DRUG is expected to report earnings on May 15, 2025.

HURA is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DRUG($250M) has a higher market cap than HURA($133M). DRUG YTD gains are higher at: -1.569 vs. HURA (-30.318). DRUG has higher annual earnings (EBITDA): -2.67M vs. HURA (-19.52M). DRUG has more cash in the bank: 57.9M vs. HURA (6.22M). HURA has less debt than DRUG: HURA (165K) vs DRUG (183K). DRUG (0) and HURA (0) have equivalent revenues.
DRUGHURADRUG / HURA
Capitalization250M133M188%
EBITDA-2.67M-19.52M14%
Gain YTD-1.569-30.3185%
P/E RatioN/AN/A-
Revenue00-
Total Cash57.9M6.22M931%
Total Debt183K165K111%
FUNDAMENTALS RATINGS
HURA: Fundamental Ratings
HURA
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DRUGHURA
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 16 days ago
89%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SVBL0.230.01
+5.50%
Silver Bull Resources, Inc.
MPZAF44.60N/A
N/A
Mips Ab
SCHYF2.37N/A
N/A
Sands China Ltd
TNGCF2.30N/A
N/A
TONGCHENG TRAVEL HLDGS LTD.
VACBF0.17N/A
N/A
NYKODE THERAPEUTICS AS

HURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HURA has been closely correlated with BIORQ. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if HURA jumps, then BIORQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HURA
1D Price
Change %
HURA100%
+0.35%
BIORQ - HURA
71%
Closely correlated
N/A
BIVI - HURA
46%
Loosely correlated
-0.93%
CMND - HURA
36%
Loosely correlated
N/A
DRUG - HURA
29%
Poorly correlated
+10.83%
AMLX - HURA
29%
Poorly correlated
-1.93%
More